Cover Image
市場調查報告書

麻痺:全球臨床實驗回顧

Paralysis Global Clinical Trials Review, H2, 2016

出版商 GlobalData 商品編碼 201137
出版日期 內容資訊 英文 83 Pages
訂單完成後即時交付
價格
Back to Top
麻痺:全球臨床實驗回顧 Paralysis Global Clinical Trials Review, H2, 2016
出版日期: 2016年09月30日 內容資訊: 英文 83 Pages
簡介

本報告提供麻痺治療藥物相關臨床實驗資料,彙整臨床實驗數及被實驗人數,各階段及各方面狀況,有潛力的企業,正在開發的治療藥物資訊,臨床實驗簡介等資料,為您概述為以下內容。

目錄

目錄
表格一覽
圖表一覽
簡介
麻痺
本報告的特色
臨床實驗 各領域
臨床實驗 各國
對臨床實驗有所貢獻的前幾名國家 - 亞太地區
對臨床實驗有所貢獻的前五國 - 歐洲
對臨床實驗有所貢獻的前幾名國家 - 北美
對臨床實驗有所貢獻的前幾名國家 - 中南美
臨床實驗 ; 金磚四國 各國
臨床實驗 各方面
進展中臨床實驗 各方面
臨床實驗 各臨床實驗狀態
每段時期的實驗人數
有潛力的贊助商
潛力治療藥物比較
臨床實驗 簡介
臨床實驗概要; 最高級大學 / 研究機關 / 醫院
Case Western Reserve University
臨床實驗概要; Case Western Reserve University
Universidad de la Republica
臨床實驗概要; Universidad de la Republica
Ramathibodi Hospital
臨床實驗概要; Ramathibodi Hospital
Katholieke Universiteit
臨床實驗概要; Katholieke Universiteit
University of Versailles
臨床實驗概要; University of Versailles
University of Campinas, Brazil
臨床實驗概要; University of Campinas, Brazil
Xijing Hospital
臨床實驗概要; Xijing Hospital
University of Alberta
臨床實驗概要; University of Alberta
Federal University of Sao Paulo
臨床實驗概要; Federal University of Sao Paulo
Rigshospitalet
臨床實驗概要; Rigshospitalet
Department of Veterans Affairs
臨床實驗概要; Department of Veterans Affairs
University of Rochester
臨床實驗概要; University of Rochester
University of East Anglia
臨床實驗概要; University of East Anglia
附錄
簡稱
定義
調查方法
二級研究
GlobalData
諮詢方式
免責聲明
資訊醬料

表格一覽

麻痺 全球藥物療法市場, 臨床實驗 各地區
麻痺 全球藥物療法市場, 臨床實驗 各國排名
麻痺 全球藥物療法市場, 進展中的臨床實驗 各國排名
麻痺 藥物療法臨床實驗, 亞太地區 ,前幾名國家
麻痺 藥物療法臨床實驗, 歐洲, 前五國
麻痺 藥物療法臨床實驗, 北美, 前幾名國家
麻痺 藥物療法臨床實驗, 中南美, 前幾名國家
麻痺 藥物療法臨床實驗, 金磚四國 各國
麻痺 全球藥物療法市場, 臨床實驗 各方面
麻痺 全球藥物療法市場, 進展中的臨床實驗 各方面
麻痺 全球藥物療法市場, 臨床實驗 各臨床實驗狀態
麻痺 全球藥物療法臨床實驗, 平均登錄對象人數趨勢
麻痺 全球藥物療法臨床實驗, 主要贊助商
麻痺 全球藥物療法臨床實驗, 臨床實驗 ; 潛力治療藥物
麻痺 全球藥物療法臨床實驗市場, 臨床實驗 ; Case Western Reserve University
麻痺 全球藥物療法臨床實驗市場, 臨床實驗 ; Universidad de la Republica
麻痺 全球藥物療法臨床實驗市場, 臨床實驗 ; Ramathibodi Hospital
麻痺 全球藥物療法臨床實驗市場, 臨床實驗 ; Katholieke Universiteit
麻痺 全球藥物療法臨床實驗市場, 臨床實驗 ; University of Versailles
麻痺 全球藥物療法臨床實驗市場, 臨床實驗 ; University of Campinas, Brazil
麻痺 全球藥物療法臨床實驗市場, 臨床實驗 ; Xijing Hospital
麻痺 全球藥物療法臨床實驗市場, 臨床實驗 ; University of Alberta
麻痺 全球藥物療法臨床實驗市場, 臨床實驗 ; Federal University of Sao Paulo
麻痺 全球藥物療法臨床實驗市場, 臨床實驗 ; Rigshospitalet
麻痺 全球藥物療法臨床實驗市場, 臨床實驗 ; Department of Veterans Affairs
麻痺 全球藥物療法臨床實驗市場, 臨床實驗 ; University of Rochester
麻痺 全球藥物療法臨床實驗市場, 臨床實驗 ; University of East Anglia

圖表一覽

麻痺 全球藥物療法市場, 臨床實驗 各地區 (%)
麻痺 全球藥物療法市場, 臨床實驗 各國排名
麻痺 全球藥物療法市場, 進展中的臨床實驗 各國排名
麻痺 藥物療法臨床實驗, 歐洲, 前五國 (%)
麻痺 藥物療法臨床實驗, 北美, 前幾名國家 (%)
麻痺 藥物療法臨床實驗, 中南美, 前幾名國家 (%)
麻痺 藥物療法臨床實驗, 金磚四國 各國 (%)
麻痺 全球藥物療法市場, 臨床實驗 各方面 (%)
麻痺 全球藥物療法市場, 進展中的臨床實驗 各方面
麻痺 全球藥物療法市場, 臨床實驗 各臨床實驗狀態
麻痺 全球藥物療法臨床實驗, 平均登錄對象人數趨勢
麻痺 全球藥物療法臨床實驗, 主要贊助商
麻痺 全球藥物療法臨床實驗, 臨床實驗 ; 潛力治療藥物
GlobalData 調查方法


本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3780CTIDB

GlobalData's clinical trial report, "Paralysis Global Clinical Trials Review, H2, 2016" provides an overview of Paralysis clinical trials scenario. This report provides top line data relating to the clinical trials on Paralysis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Paralysis to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Paralysis to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Paralysis Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Paralysis Therapeutics, Global, Clinical Trials by Region, 2016*
  • Paralysis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Paralysis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Paralysis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016*
  • Paralysis Therapeutics Clinical Trials, Europe, Top Five Countries, 2016*
  • Paralysis Therapeutics Clinical Trials, North America, Top Countries, 2016*
  • Paralysis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016*
  • Paralysis Therapeutics Clinical Trials, Central and South America, Top Countries, 2016*
  • Proportion of Paralysis to Central Nervous System Clinical Trials, G7 Countries (%), 2016*
  • Paralysis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Paralysis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Paralysis to Central Nervous System Clinical Trials, E7 Countries (%), 2016*
  • Paralysis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Paralysis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Paralysis Therapeutics, Global, Clinical Trials by Phase, 2016*
  • Paralysis Therapeutics, Global, Clinical Trials In Progress by Phase 2016*
  • Paralysis Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Paralysis Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Paralysis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Paralysis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016*
  • Paralysis Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Paralysis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Paralysis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*

List of Figures

  • Paralysis Therapeutics, Global, Clinical Trials by Region (%), 2016*
  • Paralysis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016*
  • Paralysis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016*
  • Paralysis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016*
  • Paralysis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016*
  • Paralysis Therapeutics Clinical Trials, North America, Top Countries (%), 2016*
  • Paralysis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2016*
  • Proportion of Paralysis to Central Nervous System Clinical Trials, G7 Countries (%), 2016*
  • Paralysis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016*
  • Paralysis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016*
  • Proportion of Paralysis to Central Nervous System Clinical Trials, E7 Countries (%), 2016*
  • Paralysis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016*
  • Paralysis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016*
  • Paralysis Therapeutics, Global, Clinical Trials by Phase (%), 2016*
  • Paralysis Therapeutics, Global, Clinical Trials In Progress by Phase, 2016*
  • Paralysis Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Paralysis Therapeutics Clinical Trials, Global, by End Point Status, 2016*
  • Paralysis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015
  • Paralysis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016*
  • Paralysis Therapeutics Clinical Trials, Global, Key Sponsors, 2016*
  • Paralysis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016*
  • Paralysis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016*
  • GlobalData Methodology
Back to Top